Structural basis of transcription inhibition by fidaxomicin (lipiarmycin A3)

Fidaxomicin is an antibacterial drug in clinical use for treatment of Clostridium difficile diarrhea. The active ingredient of fidaxomicin, lipiarmycin A3 (Lpm), functions by inhibiting bacterial RNA polymerase (RNAP). Here we report a cryo-EM structure of Mycobacterium tuberculosis RNAP holoenzyme...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Lin, W, Das, K, Degen, D, Mazumder, A, Duchi, D, Wang, D, Ebright, Y, Ebright, R, Sineva, E, Gigliotti, M, Srivastava, A, Mandal, S, Jiang, Y, Liu, Y, Yin, R, Zhang, Z, Eng, E, Thomas, D, Donadio, S, Zhang, H, Zhang, C, Kapanidis, A
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Cell Press 2018

Structural basis of transcription inhibition by fidaxomicin (lipiarmycin A3)

Gelijkaardige items